Search results
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks via Yahoo Finance· 3 days agoBristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails...
Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint
The Wall Street Journal· 6 days agoHEALTH NEWS Bristol Myers Squibb said on Friday that its trial evaluating a combination of cancer...
Big Pharma layoffs continue, as Bristol-Myers Squibb cuts 2,200 jobs, $1.5B in costs
BenefitsPRO· 6 days agoPatents are set to expire for the company's two top-selling drugs – the blood thinner Eliquis, which...
...Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles...
Mohave Daily News· 6 days agoAethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced ...
Bristol Myers Squibb reports setback in lung cancer trial By Investing.com
Investing.com· 6 days agoThe study evaluated the efficacy of Opdivo in combination with chemoradiotherapy, and subsequent...
PDS Biotechnology Corp. (NASDAQ:PDSB) Uses Cancer Immunotherapy to Infiltrate and Disable Tumors...
The Wall Street Transcript· 2 days agoDr. Frank Bedu-Addo has served as president and CEO of PDS Biotechnology...veteran biotech executive...
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
WFRV 5 Green Bay· 7 days agoUSA News Group – In the fight against cancer, a political stumbling block was recently put in place by the US Congress after it voted against the renewal of funding for President ...
2 Beaten-Down Stocks to Buy and Hold for 10 Years
Motley Fool via Yahoo Finance· 6 days agoHowever, the drugmaker isn't out of the woods just yet. Cancer drug Opdivo is one of the company's top-selling products, but it will ...
Is Eli Lilly Stock A Better Pick Over Amgen?
Forbes· 3 days agoAlso, Eli Lilly has seen a better revenue growth and is more profitable. There is more to the comparison, and in the sections below, we discuss why we...
Aethlon Medical Stock Surges In Pre-market On Positive Hemopurifier Trial Results
RTT News· 6 days agoIn pre-market activity on the Nasdaq, Aethlon shares were surging more than 101 percent to trade at $2.44. The company noted...of the Hemopurifier in patients with solid tumors who have stable ...